Foresite Capital Fund VI LP

Overview

• HeadquartersDE¹
• Legal formLimited Partnership
• Kind of organizationVenture capital fund¹

See how the biggest companies compare on our leaderboards

Corporate structure

Foresite Capital Fund VI LP sits at the top of its group. 8 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (7 companies). Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Managing Member of the General Partner of the IssuerJames Tananbaum named Jun 23, 2023²

Filings

2 filings to the SEC since October 2021: 2 private raises. The latest 2:

1. Jun 23, 2023D/A EDGAR
2. Jun 24, 2022D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Foresite Capital Fund VI LP has told the SEC it owns more than 5% of 7 companies, latest first (Schedules 13D and 13G).

• IRulya Therapeutics Inc.SCHEDULE 13G Oct 14, 2026³
• ALUMIS INC.SCHEDULE 13D Jul 5, 2024 to Aug 17, 2026⁴
• Latigo Biotherapeutics, Inc.SCHEDULE 13D Aug 17, 2026⁵
• Verastem OncologySCHEDULE 13G/A Oct 23, 2025 to May 15, 2026⁶
• CASI Pharmaceuticals, Inc.SCHEDULE 13G/A Jun 20, 2024 to Feb 13, 2026⁷
• enGene Therapeutics Inc.SCHEDULE 13G/A Feb 23, 2024 to Feb 14, 2025⁸
• RAPT Therapeutics, Inc.SCHEDULE 13G Dec 30, 2024⁹

Money raised

Private offerings the company reported to the SEC on Form D.

1. Jul 1, 2022Raised $551.1 million in a private offering of securities Form D: 112 investors so far Form D